Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 9599 | 1072 | 32.2 | 77% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | 9 HYDROXYRISPERIDONE | Author keyword | 93 | 83% | 5% | 53 |
| 2 | NORCLOZAPINE | Author keyword | 50 | 86% | 2% | 25 |
| 3 | PALIPERIDONE | Author keyword | 28 | 42% | 5% | 50 |
| 4 | CLOZAPINE N OXIDE | Author keyword | 21 | 73% | 1% | 16 |
| 5 | 9 HYDROXY RISPERIDONE | Author keyword | 21 | 85% | 1% | 11 |
| 6 | RISPERIDONE | Author keyword | 19 | 10% | 17% | 181 |
| 7 | DESMETHYLCLOZAPINE | Author keyword | 15 | 82% | 1% | 9 |
| 8 | POLICLIN UNIV MESSINA | Address | 9 | 83% | 0% | 5 |
| 9 | N DESMETHYLCLOZAPINE | Author keyword | 7 | 38% | 1% | 15 |
| 10 | 9 HYDROXYRISPERIDONE ENANTIOMERS | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 9 HYDROXYRISPERIDONE | 93 | 83% | 5% | 53 | Search 9+HYDROXYRISPERIDONE | Search 9+HYDROXYRISPERIDONE |
| 2 | NORCLOZAPINE | 50 | 86% | 2% | 25 | Search NORCLOZAPINE | Search NORCLOZAPINE |
| 3 | PALIPERIDONE | 28 | 42% | 5% | 50 | Search PALIPERIDONE | Search PALIPERIDONE |
| 4 | CLOZAPINE N OXIDE | 21 | 73% | 1% | 16 | Search CLOZAPINE+N+OXIDE | Search CLOZAPINE+N+OXIDE |
| 5 | 9 HYDROXY RISPERIDONE | 21 | 85% | 1% | 11 | Search 9+HYDROXY+RISPERIDONE | Search 9+HYDROXY+RISPERIDONE |
| 6 | RISPERIDONE | 19 | 10% | 17% | 181 | Search RISPERIDONE | Search RISPERIDONE |
| 7 | DESMETHYLCLOZAPINE | 15 | 82% | 1% | 9 | Search DESMETHYLCLOZAPINE | Search DESMETHYLCLOZAPINE |
| 8 | N DESMETHYLCLOZAPINE | 7 | 38% | 1% | 15 | Search N+DESMETHYLCLOZAPINE | Search N+DESMETHYLCLOZAPINE |
| 9 | 9 HYDROXYRISPERIDONE ENANTIOMERS | 6 | 80% | 0% | 4 | Search 9+HYDROXYRISPERIDONE+ENANTIOMERS | Search 9+HYDROXYRISPERIDONE+ENANTIOMERS |
| 10 | CLOZAPINE METABOLITES | 6 | 80% | 0% | 4 | Search CLOZAPINE+METABOLITES | Search CLOZAPINE+METABOLITES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 9 HYDROXYRISPERIDONE | 128 | 70% | 10% | 106 |
| 2 | NORCLOZAPINE | 61 | 77% | 4% | 41 |
| 3 | DESMETHYLCLOZAPINE | 48 | 74% | 3% | 35 |
| 4 | CYTOCHROMES P450 2D6 | 35 | 76% | 2% | 25 |
| 5 | DESMETHYLOLANZAPINE | 34 | 93% | 1% | 13 |
| 6 | REFRACTORY SCHIZOPHRENIC PATIENTS | 29 | 56% | 3% | 35 |
| 7 | ANTIPSYCHOTIC AGENT OLANZAPINE | 28 | 64% | 3% | 28 |
| 8 | PLASMA CLOZAPINE | 26 | 68% | 2% | 23 |
| 9 | ANTIPSYCHOTIC DRUG QUETIAPINE | 23 | 100% | 1% | 10 |
| 10 | CAFFEINE TEST | 23 | 74% | 2% | 17 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Advances in detection of antipsychotics in biological matrices | 2015 | 1 | 61 | 36% |
| Metabolism of atypical antipsychotics: Involvement of cytochrome P450 enzymes and relevance for drug-drug interactions | 2008 | 65 | 102 | 72% |
| Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold? | 2013 | 10 | 82 | 65% |
| Metabolic drug interactions with newer antipsychotics: A comparative review | 2007 | 106 | 150 | 65% |
| Clinically relevant interactions between newer antidepressants and second-generation antipsychotics | 2014 | 5 | 95 | 36% |
| Atypical Antipsychotic Metabolism and Excretion | 2010 | 26 | 52 | 71% |
| Clinically Significant Drug Interactions with Atypical Antipsychotics | 2013 | 8 | 117 | 64% |
| Clinical pharmacokinetics of atypical antipsychotics - A critical review of the relationship between plasma concentrations and clinical response | 2007 | 125 | 144 | 47% |
| A review of the use of clozapine levels to guide treatment and determine cause of death | 2012 | 7 | 87 | 55% |
| Risperidone in Schizophrenia: Is There a Role for Therapeutic Drug Monitoring? | 2011 | 12 | 61 | 61% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | POLICLIN UNIV MESSINA | 9 | 83% | 0.5% | 5 |
| 2 | MEMS SENSORS ACTUATORS MSAL | 3 | 50% | 0.5% | 5 |
| 3 | EASTERN STATE HOSP | 2 | 14% | 0.9% | 10 |
| 4 | COURSE BASIC CLIN SCI | 1 | 100% | 0.2% | 2 |
| 5 | INTERNAL MEDCLIN NEUROPSYCHOPHARMACOL UNIT | 1 | 100% | 0.2% | 2 |
| 6 | MENTAL HLTH CSM | 1 | 100% | 0.2% | 2 |
| 7 | SHEPPARD PRATT PSYCHIAT IDENCY PROGRAM | 1 | 50% | 0.2% | 2 |
| 8 | KLIN KONIGSFELDEN | 1 | 33% | 0.3% | 3 |
| 9 | BIOPHARM PHARM CLIN | 1 | 30% | 0.3% | 3 |
| 10 | TDM TOXICOL | 1 | 30% | 0.3% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000225225 | CLOZAPINE//RISPERIDONE//OLANZAPINE |
| 2 | 0.0000193090 | CYP1A2//CAFFEINE METABOLISM//CYP1A2 ACTIVITY |
| 3 | 0.0000177311 | SERTINDOLE//PSYCHOPHARMACOL VENTURE//TROP TOXINOL UNIT |
| 4 | 0.0000138029 | SOUR CHERRY SEED EXTRACT//SOUR CHERRY KERNEL//ANTI PSYCHOTIC DRUG |
| 5 | 0.0000107454 | MICROEXTRACTION IN PACKED SYRINGE//MICROEXTRACTION BY PACKED SORBENT//POLYSTYRENE SORBENT |
| 6 | 0.0000094087 | ARIPIPRAZOLE//ASENAPINE//ILOPERIDONE |
| 7 | 0.0000085314 | DRD3//T102C POLYMORPHISM//TARDIVE DYSKINESIA |
| 8 | 0.0000079507 | ANTIPSYCHOTIC POLYPHARMACY//POLYPHARMACY//TUNKU ABDUL RAHMAN NEUROSCI |
| 9 | 0.0000078596 | REDUCED HALOPERIDOL//BROMPERIDOL//REDUCED BROMPERIDOL |
| 10 | 0.0000073140 | NORTRIPTYLINE//DESMETHYLCLOMIPRAMINE//DOXEPIN |